Clinical and Preclinical Rationale for CGRP‐Receptor Antagonists in the Treatment of Migraine
Authors:
- 2 September 2008
- journal article
- review article
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 48 (8) , 1259-1268
Abstract
Calcitonin gene‐related peptide (CGRP) is linked to migraine and other primary headache disorders. It is found in every location described in migraine genesis and processing, including meninges, trigeminal ganglion, trigeminocervical complex, brainstem nuclei, and cortex. It is released in animal models following stimulation of the CNS similar to that seen in migraine, and triptans inhibit this release. Injection of CGRP into migraineurs results in delayed headache similar to migraine. Elevation of CGRP occurs during migraine, resolving following migraine‐specific treatment. Finally, and most importantly, CGRP receptor antagonists terminate migraine with efficacy similar to triptans. Both intravenous olcegepant (BIBN 4096 BS) and oral telcagepant (MK‐0974) have been effective, safe, and well tolerated in phase I and II studies. Telcagepant is currently in phase III trials, and preliminary results are favorable. The potential for a migraine‐specific medication without vasoconstrictive or vascular side effects is enormous. CGRP receptor blockade may also have applications in other pathologic and pain syndromes.Keywords
This publication has 63 references indexed in Scilit:
- Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraineNeurology, 2008
- Calcitonin gene‐related peptide enhances release of native brain‐derived neurotrophic factor from trigeminal ganglion neuronsJournal of Neurochemistry, 2006
- Critical Role of Calcitonin Gene-Related Peptide 1 Receptors in the Amygdala in Synaptic Plasticity and Pain BehaviorThe Journal of Neuroscience, 2005
- Calcitonin gene–related peptide does not excite or sensitize meningeal nociceptors: Implications for the pathophysiology of migraineAnnals of Neurology, 2005
- No increase of calcitonin gene–related peptide in jugular blood during migraineAnnals of Neurology, 2005
- The Nonpeptide Calcitonin Gene-Related Peptide Receptor Antagonist BIBN4096BS Lowers the Activity of Neurons with Meningeal Input in the Rat Spinal Trigeminal NucleusJournal of Neuroscience, 2005
- The CGRP-Antagonist, BIBN4096BS Does not Affect Cerebral or Systemic Haemodynamics in Healthy VolunteersCephalalgia, 2005
- Neurobiology of migraineNature Reviews Neuroscience, 2003
- Calcitonin Gene-Related Peptide in the Regulation of Cardiac FunctionAnnals of the New York Academy of Sciences, 1992
- Vasoactive peptide release in the extracerebral circulation of humans during migraine headacheAnnals of Neurology, 1990